Psychology Protocol-Based Services

Protocol Assessment

Protocol-based psychological assessment is often conducted as part of therapeutic protocols. Tests selected for protocol assessment are the same for all patients who take part in the study, and they are selected to address a research question. Brief feedback is provided to families of patients who complete protocol-based psychological assessment, and clinical assessment is sometimes recommended if specific areas of weakness are identified. Some examples of therapeutic research protocols with a psychological assessment component are: RT2CR, SCDMR4, SJMB03, SJYC07, and TOTXVI.

Supportive Psychological Protocol Services

The Psychology Department also conducts a number of non-therapeutic, supportive protocols.

CSqHPV: Vaccine Therapy in Preventing Human Papillomavirus Infection in Younger Cancer Survivors

Quadrivalent Human Papillomavirus (qHPV) Vaccine in Cancer Survivors: Cross Sectional Survey and Phase II Open-Label Vaccine Trial A Consortium for Pediatric Interventional Research

Diseases Treated:

Human papillomavirus

Eligibility:

This is a non-therapeutic clinical trial that is only open to St. Jude patients.

Questionnaire phase

  • Cancer survivor (9 to 26 years of age at study participation)
  • English or Spanish-speaking

Vaccine Phase

  • Survey response indicated no prior history of HPV vaccination
  • Agrees to return to participating institution for 3 HPV vaccine injections
  • Allergy to any component of the HPV vaccine including yeast and aluminum will not be eligible for the study
View Trial

DIARY1: The Feasibility of a Daily Diary Methodology with a Pediatric Cancer Population: A Pilot Study

Eligibility:

This is a non-therapeutic clinical trial that is only open to St. Jude patients.

This clinical trial requires pediatric participants (Phase I and II) as well as control participants. Please see Eligibility Criteria section for details.

View Trial

LITE: Light Therapy to Increase Energy in Adolescents with Solid Tumors: A Pilot Study

Diseases Treated:

Solid tumors

Eligibility:

This is a non-therapeutic clinical trial that is only open to St. Jude patients.

  • Participant is between the ages of twelve (12) and eighteen (18) years old. 
  • Participant has been diagnosed with a solid tumor within the past thirty (30) days. 
  • Participant is not blind and does not have a history of eye disease including, but not limited to macular degeneration, or other diagnosed retinal problems. 
  • Participant has not initiated antidepressant medication, including either SSRIs in the past month, and MAOIs in the past two months. 
  • Participant has not undergone laser corrective eye surgery in the past thirty (30) days.
View Trial

MEMREAD: Working Memory and School Readiness in Preschool-aged Children with Sickle Cell Disease: Family and Environmental Factors

Diseases Treated:

Sickle cell disease

Eligibility:

This is a non-therapeutic clinical trial open to St. Jude patients only.

View Trial

MPST3: Online Problem Solving Skills Training

Online Implementation of Problem-Solving Skills Training for Parents of Newly Diagnosed Childhood Cancer Patients

Eligibility:

This is a non-therapeutic clinical trial that is only open to St. Jude patients.

  • Please see the eligibility section on the clinical trial for full inclusion and exclusion criteria.
View Trial

PEESC: Evaluation of Nocturnal Enuresis and Barriers to Treatment Among Pediatric Patients with Sickle Cell Disease

Diseases Treated:

Sickle cell disease

Eligibility:

This is a non-therapeutic clinical trial that is only open to St. Jude patients.

View Trial

SBANK10: Sperm Banking Among Adolescents Newly Diagnosed with Cancer: Development of a Profiling and Referral Tool

Eligibility:

This is a non-therapeutic clinical trial that is only open to St. Jude patients.

View Trial

XPD12-077: Cognitive, Academic and Psychosocial Functioning in Long-Term Survivors of Pediatric Stem Cell Transplantation

Eligibility:

This is a non-therapeutic clinical trial that is only open to St. Jude patients.

View Trial